Alzheimer's disease: Low levels of peptide a-amidation activity in brain and CSF

G. S. Wand; C. May; V. May; P. J. Whitehouse; S. I. Rapoport; B. A. Eipper

doi:10.1212/wnl.37.6.1057

Alzheimer's disease: Low levels of peptide a-amidation activity in brain and CSF

G. S. Wand, C. May, V. May, P. J. Whitehouse, S. I. Rapoport, B. A. Eipper

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Carboxyl terminal a-amidation confers biologic activity to many neuropeptides. Levels of a-amidating activity, peptidyl-glycine α-amidating monooxygenase (PAM), were reduced in the CSF of patients with dementia of the Alzheimer type (DAT) compared with healthy, age-matched controls. Repeat lumbar puncture data revealed a decline in CSF PAM activity of approximately 16% per year in DAT patients. Of the cerebral cortical regions examined, only the temporal pole showed reduced PAM activity in patients with Alzheimer's disease (AD) compared with controls. These studies may indicate selective dysfunction of neurons which normally synthesize biologically active, a-amidated peptides in the CNS of AD patients.

Original language	English (US)
Pages (from-to)	1057-1061
Number of pages	5
Journal	Neurology
Volume	37
Issue number	6
DOIs	https://doi.org/10.1212/wnl.37.6.1057
State	Published - Jun 1987
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/wnl.37.6.1057

Cite this

@article{300ea9cec81f467f890cb9b1e6985978,

title = "Alzheimer's disease: Low levels of peptide a-amidation activity in brain and CSF",

abstract = "Carboxyl terminal a-amidation confers biologic activity to many neuropeptides. Levels of a-amidating activity, peptidyl-glycine α-amidating monooxygenase (PAM), were reduced in the CSF of patients with dementia of the Alzheimer type (DAT) compared with healthy, age-matched controls. Repeat lumbar puncture data revealed a decline in CSF PAM activity of approximately 16% per year in DAT patients. Of the cerebral cortical regions examined, only the temporal pole showed reduced PAM activity in patients with Alzheimer's disease (AD) compared with controls. These studies may indicate selective dysfunction of neurons which normally synthesize biologically active, a-amidated peptides in the CNS of AD patients.",

author = "Wand, {G. S.} and C. May and V. May and Whitehouse, {P. J.} and Rapoport, {S. I.} and Eipper, {B. A.}",

year = "1987",

month = jun,

doi = "10.1212/wnl.37.6.1057",

language = "English (US)",

volume = "37",

pages = "1057--1061",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Alzheimer's disease

T2 - Low levels of peptide a-amidation activity in brain and CSF

AU - Wand, G. S.

AU - May, C.

AU - May, V.

AU - Whitehouse, P. J.

AU - Rapoport, S. I.

AU - Eipper, B. A.

PY - 1987/6

Y1 - 1987/6

N2 - Carboxyl terminal a-amidation confers biologic activity to many neuropeptides. Levels of a-amidating activity, peptidyl-glycine α-amidating monooxygenase (PAM), were reduced in the CSF of patients with dementia of the Alzheimer type (DAT) compared with healthy, age-matched controls. Repeat lumbar puncture data revealed a decline in CSF PAM activity of approximately 16% per year in DAT patients. Of the cerebral cortical regions examined, only the temporal pole showed reduced PAM activity in patients with Alzheimer's disease (AD) compared with controls. These studies may indicate selective dysfunction of neurons which normally synthesize biologically active, a-amidated peptides in the CNS of AD patients.

AB - Carboxyl terminal a-amidation confers biologic activity to many neuropeptides. Levels of a-amidating activity, peptidyl-glycine α-amidating monooxygenase (PAM), were reduced in the CSF of patients with dementia of the Alzheimer type (DAT) compared with healthy, age-matched controls. Repeat lumbar puncture data revealed a decline in CSF PAM activity of approximately 16% per year in DAT patients. Of the cerebral cortical regions examined, only the temporal pole showed reduced PAM activity in patients with Alzheimer's disease (AD) compared with controls. These studies may indicate selective dysfunction of neurons which normally synthesize biologically active, a-amidated peptides in the CNS of AD patients.

UR - http://www.scopus.com/inward/record.url?scp=0023255792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023255792&partnerID=8YFLogxK

U2 - 10.1212/wnl.37.6.1057

DO - 10.1212/wnl.37.6.1057

M3 - Article

C2 - 3587629

AN - SCOPUS:0023255792

SN - 0028-3878

VL - 37

SP - 1057

EP - 1061

JO - Neurology

JF - Neurology

IS - 6

ER -

Alzheimer's disease: Low levels of peptide a-amidation activity in brain and CSF

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this